Schonfeld Strategic Advisors LLC

Position in FATE — Fate Therapeutics Inc

CIK 1665241 NEW YORK, NY

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$178,626

-$10,202 QoQ

Shares Held

66,158

-65.7% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#64

of 156 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. FATE ranks #104 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$178,626	66,158	-65.7%	Shares	Sole	2026-08-14
2025-12-31	$188,828	192,682	-64.6%	Shares	Sole	2026-02-17
2025-09-30	$686,179	544,587	-41.5%	Shares	Sole	2025-11-14
2025-06-30	$1,042,506	930,809	-88.1%	Shares	Sole	2025-08-14
2025-03-31	$6,157,665	7,794,513	+778.8%	Shares	Sole	2025-05-15
2024-03-31	$6,510,029	886,925	+78.3%	Shares	Sole	2024-05-15
2023-12-31	$1,860,489	497,457	+2490.9%	Shares	Sole	2024-02-14
2023-09-30	$40,704	19,200	-86.2%	Shares	Sole	2023-11-14
2022-12-31	$1,402,510	139,000	+63.8%	Shares	Sole	2023-02-14
2022-09-30	$1,901,622	84,856	-15.6%	Shares	Sole	2022-11-14
2022-06-30	$2,492,669	100,592	+2343.3%	Shares	Sole	2022-08-15
2020-12-31	$374,358	4,117	-54.8%	Shares	Sole	2021-02-16
2020-09-30	$364,246	9,113	—	Shares	Sole	2020-11-19
No filing history on record for this holder in this stock.